Research-grade Semaglutide is manufactured for in-vitro and preclinical laboratory use only, not under GMP pharmaceutical regulations required for human drugs like Ozempic or Wegovy
The FDAs decision to ban compounded medications is a regulatory action aimed at addressing safety concerns associated with drugs that are made by compounding pharmacies
The FDA-approved labeling for semaglutide and tirzepatide does not list liver disease as a contraindication, and no dose adjustments are required for hepatic impairment
In a two-year clinical trial of Ozempic, acute pancreatitis a sudden but treatable condition was observed in a small number of patients taking Ozempic, but more cases of pancreatitis were observed in patients given a placebo
One wrong calculation can mean weeks of side effects from an accidental overdose, or weeks of zero progress from an underdose
Daily weight fluctuates by 2 to 5 pounds based on water retention, sodium intake, bowel activity, and hormonal cycles